Apr 04, 2016 05:50 am UTC| Business
PARIS, April 4, 2016 -- AB Science Announces Positive Interim Results from Phase 3 Trial of Masitinib in Amyotrophic Lateral Sclerosis (ALS) (also known as Lou Gehrig's disease) Company to Host Webcast on...
Singapore selects Gemalto for mobile NFC ticketing solution
Apr 04, 2016 05:00 am UTC| Business
AMSTERDAM, April 4, 2016 -- Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, is for the first time making it possible for Singapore public transit commuters to pay their fare using their mobile...
Apr 03, 2016 22:16 pm UTC| Business
NEW YORK, April 03, 2016 -- In a release issued under the same headlineon February 4th, 2016byPomerantz LLP, the deadline mentioned in the second paragraph should be April 4, 2016 and not April 6, 2016 as previously...
Galapagos increases share capital through warrant exercises
Apr 03, 2016 20:29 pm UTC| Business
MECHELEN, Belgium, April 3, 2016 -- Galapagos NV (Euronext NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 131,695 new ordinary shares on 1April2016, for a total...
Apr 03, 2016 17:15 pm UTC| Business
--bestPWS Study is the first Phase 3 pivotal trial to show significant weight-loss and improvement in hyperphagia-related behaviors in PWS patients-- --Beloranib was associated with improvement in total cholesterol, LDL...
Alder Presents Preclinical Data for ALD1613 at ENDO 2016
Apr 03, 2016 17:15 pm UTC| Business
BOTHELL, Wash., April 03, 2016 -- Alder BioPharmaceuticals, Inc. (“Alder”) (NASDAQ:ALDR), today announced that preclinical data on ALD1613, its anti-adrenocorticotropic hormone (ACTH) antibody for the treatment of...
Ultimate Performance Chiro & Rehab Announces that Integrative Medicine is the New Medicine
Apr 03, 2016 14:00 pm UTC| Business
LAKE CHARLES, La., April 03, 2016 -- Over the past 50 years, more and more studies have been performed on what is commonly known as alternative therapies or complementary therapies. Although these two forms of medicine...